I. INDUSTRY ALLIANCE INDUCTION
The Shenzhen Biomedical Industry Alliance (SBIA) convened its 1st Second General Assembly at the River Delta Innovation Hub Conference Center. Focused on "Resource Integration & Technology Commercialization", the session reviewed SBIA’s inaugural-year achievements and strategic roadmap before governmental agencies and member organizations.
Key Milestone
- Optoseeker formally inducted as SBIA member through official alliance credential presentation.
- Participation in closed-door roundtables on biopharma R&D acceleration and industrial pathways.
Strategic Significance
① Policy Synergy – Embodies Shenzhen’s "20+8 Industrial Clusters" strategy for advanced instrumentation
② Technology Leadership – Drives optoelectronic tweezer adoption in antibody/CAR-T therapy industrialization
③ Global Impact – Accelerates China’s transition from manufacturing scale to technology sovereignty in life sciences
II. WUHAN DISTRIBUTION SUMMIT RECAP
"Growth Convergence • Shared Prosperity" - CLSC 2025
(April 12, Wuhan) Optoseeker hosted China’s premier scientific channel partners at the Central Laboratory Supply Chain Summit.
Engagement Highlights
- Technology Showcases
- Interactive opto-microfluidics demos (DropletBot®/OptoBot® series)
- Precision performance validation: Sub-μm resolution, 99.8% single-cell capture rate
- Partner Recruitment
- Secured 17 regional distribution agreements covering Central/Western China
- Established OEM collaboration framework with 3 IVD leaders
